DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas ; volume:23 ; number:1 ; day:6 ; month:5 ; year:2023 ; pages:1-14 ; date:12.2023
BMC neurology ; 23, Heft 1 (6.5.2023), 1-14, 12.2023
- Urheber
-
Han, Myung-Hoon
Baek, Jeong Min
Min, Kyueng-Whan
Cheong, Jin Hwan
Ryu, Je Il
Won, Yu Deok
Kwon, Mi Jung
Koh, Seong-Ho
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-023-03236-0
- URN
-
urn:nbn:de:101:1-2023090610383657262690
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Han, Myung-Hoon
- Baek, Jeong Min
- Min, Kyueng-Whan
- Cheong, Jin Hwan
- Ryu, Je Il
- Won, Yu Deok
- Kwon, Mi Jung
- Koh, Seong-Ho
- SpringerLink (Online service)
Ähnliche Objekte (12)
High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas
Chemical immunosuppression
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
High metallothionein predicts poor survival in glioblastoma multiforme
Radiotherapy for glioblastoma patients with poor performance status
Membrane Hsp70 expression in gliomas : a novel, hypoxia-related marker for primary glioblastoma
High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas
Chemical immunosuppression
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
High metallothionein predicts poor survival in glioblastoma multiforme
Radiotherapy for glioblastoma patients with poor performance status
Membrane Hsp70 expression in gliomas : a novel, hypoxia-related marker for primary glioblastoma
High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach
STING cg16983159 methylation: a key factor for glioblastoma immunosuppression
CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma
Immunosuppression
Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas
Chemical immunosuppression
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
High metallothionein predicts poor survival in glioblastoma multiforme
Radiotherapy for glioblastoma patients with poor performance status